Among the laboratory findings-based adverse reactions, elevation of AST or ALT was the most frequent, occurring in 5 of the 52 patients (9.1%), followed by neutropenia (1.8%), elevation of creatinine (1.8%), and hyper bilirubinemia (1.8%). This evidence concerns the gene GPT and Decreased total neutrophil count.